Periodontal disease in HIV-infected adults in the HAART era: Clinical, immunological, and microbiological aspects

Archives of Oral Biology

Volumn 58, Issue 10, 2013, Pages 1385-1396

  Gonçalves, Lucio Souza ^a   Gonçalves, Barbara Mulatinho Lopo ^b   Fontes, Tatiana Vasconcellos ^a  

^a ESTÁCIO DE SÁ UNIVERSITY   (Brazil)

^b Center for Integrated Dentists   (Brazil)

Author keywords

Highly active antiretroviral therapy; HIV infection; Immunology; Microbiology; Periodontal diseases

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

ADULT; BIOFILM; DRUG EFFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; MICROBIOLOGY; PERIODONTAL DISEASE; REVIEW;

HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTION; IMMUNOLOGY; MICROBIOLOGY; PERIODONTAL DISEASES;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOFILMS; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; PERIODONTAL DISEASES;

EID: 84888030174     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2013.05.002     Document Type: Review

References (115)

1. Horstmann E, Brown J, Islam F, Buck J, Agins B. Retaining HIV-infected patients in care: where are we? Where do we go from here? Clinical Infectious Diseases 2010;50:752-61.
2. UNAIDS. Chronic care of HIV and non-communicable diseases: how to leverage the HIV experience. 2011.
3. Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Annals of Internal Medicine 2002;137:381-433.
4. UNAIDS. Report on the global HIV/AIDS epidemic. 2008.
5. Palella Jr FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine 1998;13:853-60.
6. Schmidt-Westhausen AM, Priepke F, Bergman FJ, Reichart PA. Decline in the rate of oral opportunistic infections following introduction of highly active retroviral therapy. Journal of Oral Pathology and Medicine 2000;29:336-41.
7. Greenspan JS, Greenspan D. The epidemiology of the oral lesions of HIV infection in the developed world. Oral Diseases 2002;8(Suppl. 2):34-9.
8. Ramirez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Anaya-Saavedra G, Gonzalez-Ramirez I, Ponce-de-Leon S. The changing clinical spectrum of human immunodeficiency virus (HIV)-related oral lesions in 1,000 consecutive patients: a 12 year study in a referral centre in Mexico. Medicine 2003;82:39-50.
9. Bascones A, Serrano C, Campo J. Oral manifestations of HIV infection. Medicina Clinica 2003;120:426-34.
10. Robinson PG, Adegboye A, Rowland RW, Yeung S, Johnson N. Periodontal disease and HIV infection. Oral Diseases 2002;8(Suppl. 2):144-50.
11. Barr C, Lopez MR, Rua-Dobles A. Periodontal changes by HIV serostatus in a cohort of homosexual and bisexual men. Journal of Periodontology 1992;19:794-801.
12. Maticic M, Poljak M, Kramar B, Tomazic J, Vidmar L, Zakotnik B, et al. Proviral HIV-1 DNA in gingival crevicular fluid of HIV 1-infected patients in various stages of HIV disease. Journal of Dental Research 2000;79:1496-501.
13. McKaig RG, Patton LL, Thomas JC, Strauss RP, Slade GD, Beck JD. Factors associated with periodontitis in an HIV-infected southeast USA study. Oral Diseases 2000;6:158-65.
14. Hofer D, Hämmerle CH, Grassi M, Lang NP. Long-term results of supportive periodontal therapy (SPT) in HIV-seropositive and HIV-seronegative patients. Journal of Clinical Periodontology 2002;29:630-7.
15. Gonçalves LS, Ferreira SM, Silva Jr A, Villoria GE, Costinha LH, Colombo AP. Association of T CD4 lymphocyte levels and chronic periodontitis in HIV-infected Brazilian patients undergoing highly active anti-retroviral therapy. Clinical results. Journal of Periodontology 2005;76:906-13.
16. Alves M, Mulligan R, Passaro D, Gawell S, Navazesh M, Phelan J, et al. Longitudinal evaluation of loss of attachment in HIV-infected women compared to HIV-uninfected women. Journal of Periodontology 2006;77:773-9.
17. Gonçalves LS, Ferreira SM, Souza CO, Souto R, Colombo AP. Clinical and microbiological profiles of human immunodeficiency virus (HIV)-seropositive Brazilians undergoing highly active antiretroviral therapy and HIV-seronegative Brazilians with chronic periodontitis. Journal of Periodontology 2007;78:87-96.
18. Aichelmann-Reidy ME, Wrigley DL, Gunsolley JC. HIV infection and bone loss due to periodontal disease. Journal of Periodontology 2010;81:877-84.
19. Fricke U, Geurtsen W, Staufenbiel I, Rahman A. Periodontal status of HIV-infected patients undergoing antiretroviral therapy compared to HIV-therapy naïve patients: a case control study. European Journal of Medical Research 2012;17:2.
20. Gonçalves LS, Ferreira SM, Silva Jr A, Villoria GE, Costinha LH, Souto R, et al. Association of TCD4 lymphocyte levels and subgingival microbiota of chronic periodontitis in HIV-infected Brazilian under HAART. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 2004;97:196-203.
21. Munro CA, Hube B. Anti-fungal therapy at the HAART of viral therapy. Trends in Microbiology 2002;10:173-7.
22. Ryder MI. An update on HIV and periodontal disease. Journal of Periodontology 2002;73:1071-8.
23. Yin MT, Dobkin JF, Grbic JT. Epidemiology, pathogenesis, and management of human immunodeficiency virus infection in patients with periodontal disease. Periodontology 2000 2007;44:55-81.
24. Armitage GC. Development of a classification system for periodontal diseases and conditions. Annals of Periodontology 1999;4:1-6.
25. Sanz M, van Winkelhoff AJ. Working group 1 of seventh European Workshop on Periodontology. Periodontal infections: understanding the complexity - consensus of the seventh European workshop on periodontology. Journal of Clinical Periodontology 2011;38(Suppl. 11):3-6.
26. Offenbacher S. Periodontal diseases: pathogenesis. Annals of Periodontology 1996;1:821-78.
27. Page RC, Kornman KS. The pathogenesis of human periodontitis: an introduction. Periodontology 2000 1997;14:9-11.
28. Winkler JR, Murray PA. Periodontal disease. A potential intraoral expression of AIDS may be rapidly progressive periodontitis. CDA Journal 1987;15:20-4.
29. Holmstrup P. Nonplaque-induced gingival lesions. Annals of Periodontology 1999;4:20-31.
30. Reznik DA. Oral manifestations of HIV disease. Topics in HIV Medicine 2006;13:143-8.
31. Grbic JT, Mitchell-Lewis DA, Fine JB, Phelan JA, Bucklan RS, Zambon JJ, et al. The relationship of candidiasis to linear gingival erythema in HIV-infected homosexual men and parenteral drug users. Journal of Periodontology 1995;66:30-7.
32. Jabra-Rizk MA, Ferreira SM, Sabet M, Falkler WA, Merz WG, Meiller TF. Recovery of Candida dubliniensis and other yeast from human immunodeficiency virus associated periodontal lesions. Journal of Clinical Microbiology 2001;39:4520-2.
33. Gómez RS, da Costa JE, Loyola AM, de Araújo NS, de Araújo VC. Immunohistochemical study of linear gingival erythema from HIV-positive patients. Journal of Periodontal Research 1995;30:355-9.
34. Lamster IB, Grbic JT, Fine J, BucklanR. Mitchell-Lewis D, Phelan J, et al. A critical review of periodontal disease as a manifestation of HIV infection. In: Greenspan JS, Greenspan D, editors. Oral Manifestations of HIV Infection. Chicago: Quintessence Publishing Company; 1995. p. 247-56.
35. Patton LL. Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 2000;90:182-8.
36. Novak MJ. Necrotizing ulcerative periodontitis. Annals of Periodontology 1999;4:74-8.
37. Lang N, Soskolne WA, Greenstein G, Chrocan D, Corbet E, Meng HX, et al. Consensus report: necrotizing periodontal diseases. Annals of Periodontology 1999;4:78.
38. Cross DL, Smith GLF. Comparison of periodontal disease in HIV seropositive subjects and controls. (II) Microbiology, immunology and predictors of disease progression. Journal of Clinical Periodontology 1995;22:569-77.
39. Glick M, Muzyka BC, Salkin LM, Lurie D. Necrotizing ulcerative periodontitis: a marker for immune deterioration and a predictor for the diagnosis of AIDS. Journal of Periodontology 1994;65:393-7.
40. Lamster IB, Grbic JT, Bucklan RS, Mitchel LD, Reynolds HS, Zambon JJ. Epidemiology and diagnosis of HIV associated periodontal diseases. Oral Diseases 1997;3(suppl 1):141-8.
41. Epstein JB, Leziy S, Ransier A. Periodontal pocketing in HIV associated periodontitis. Special Care in Dentistry 1993;3:236-40.
42. Shangase L, Feller L, Blignaut E. Necrotizing ulcerative gingivitis/periodontitis as indicators of HIV-infection. Small Arms Defense Journal 2004;59:105-8.
43. Glick M, Muzyka BC, Luried D, Salkin LM. Oral Manifestations associated with HIV related disease as markers for immune suppression and AIDS. Oral Surgery Oral Medicine Oral Pathology 1994;77:344-9.
44. Wood NH, Blignaut E, Lemmer J, Meyerov R, Feller L. Necrotizing periodontal diseases in a semirural district of South Africa. AIDS Research and Treatment 2011. http://dx.doi.org/10.1155/2011/638584. [Epub 2011 Jun 21].
45. National Program for STD and AIDS/Bulletin November 2009. Brasilia, DF: Brazilian Ministry of Health (in Portuguese).
46. Shelburne 3rd SA, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL, Musher DW, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 2002;81:213-27.
47. Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infectious Diseases 2007;7:395-401.
48. Yeung SC, Stewart GJ, Cooper DA, Sindhusake D. Progression of periodontal disease in HIV seropositive patients. Journal of Periodontology 1993;64:651-7.
49. Tomar SL, Swango A, Kleinman DV, Burt BA. Loss of periodontal attachment in HIV-seropositive military personnel. Journal of Periodontology 1995;66:421-8.
50. Robinson PG, Sheiham A, Challacombe SJ, Zakrzewska JM. The periodontal health of homosexual men with HIV infection: a controlled study. Oral Diseases 1996;2:45-52.
51. Ndiaye CF, Critchlow CW, Leggott PJ, Kiviat NB, Ndoye I, Robertson PB, et al. Periodontal status of HIV-1 and HIV-2 seropositive and HIV seronegative female commercial sex workers in Senegal. Journal of Periodontology 1997;68:827-31.
52. Swango PA, Kleinman DV, Konzelman JL. HIV and periodontal health. A study of military personnel with HIV. Journal of the American Dental Association 1991;122:49-54.
53. Winkler JR, Grassi M, Murray PA. Clinical description and etiology of HIV associated periodontal diseases. In: Robertson PB, Greenspan JS, editors. Perspectives on oral manifestations of AIDS. Littleton, CO: PSG Publishing Co. Inc.; 1988. p. 49-70.
54. Silva Jr A, Ferreira SMS, Perez MA, Albuquerque EB, Camilo RS, Torres SR. Experience on 584 HIV + patients of a dental referal center. Tenth international conference on AIDS - international conference on STD. 1994.
55. Bertazzoli R, Lourenço C. Oral Manifestation. Oral manifestations of HIV infection in Campinas city. Tenth international conference on AIDS - international conference on STD. 1994.
56. Ferreira S, Noce C, Júnior AS, Gonçalves L, Torres S, Meeks V, et al. Prevalence of oral manifestations of HIV infection in Rio de Janeiro, Brazil from 1988 to 2004. AIDS Patient Care STDS 2007;21:724-31.
57. Ceballos-Salobreña A, Gaitán-Cepeda LA, Ceballos-Garcia L, Lezama-Del Valle D. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS? Aids Patient Care and STDS 2000;14:627-35.
58. Nittayananta W, Talungchit S, Jaruratanasirikul S, Silpapojakul K, Chayakul P, Nilmanat A, et al. Effects of long-term use of HAART on oral health status of HIV-infected subjects. Journal of Oral Pathology and Medicine 2010;39:397-406.
59. Patton LL, Phelan JA, Ramos-Gomez FJ, Nittayananta W, Shiboski CH, Mbuguye TL. Prevalence and classification of HIV-associated oral lesions. Oral Diseases 2002;8(Suppl. 2):98-109.
60. Sontakke SA, Umarji HR, Karjodkar F. Comparison of oral manifestations with CD4 count in HIV-infected patients. Indian Journal of Dental Research 2011;22:732.
61. Gaurav S, Keerthilatha PM, Archna N. Prevalence of oral manifestations and their association with CD4/CD8 ratio and HIV viral load in South India. International Journal of Dentistry 2011;2011:964278. http://dx.doi.org/10.1155/ 2011/964278. [Epub 2011 Oct 20].
62. Hans M, Hans VM. Toll-like receptors and their dual role in periodontitis: a review. Journal of Oral Science 2011;53:263-71.
63. Scott DA, Krauss J. Neutrophils in periodontal inflammation. Frontiers of Oral Biology 2012; 15:56-83.
64. Alpagot T, Duzgunes N, Wolff LF, Lee A. Risk factors for periodontitis in HIV+ patients. Journal of Periodontal Research 2004;39:149-57.
65. Alpagot T, Suzara V, Bhattacharyya M. The associations between gingival crevice fluid matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and periodontitis in human immunodeficiency virus-positive patients. Journal of Periodontal Research 2006;41:491-7.
66. Offenbacher S, Odle BM, Van Dyke TE. The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. Journal of Periodontal Research 1986;21:101-12.
67. Hessle CC, Andersson B, Wold AE. Gram-negative, but not Gram-positive, bacteria elicit strong PGE2 production in human monocytes. Inflammation 2003;27:329-32.
68. Dunne DW, Shaw A, Bockenstedt LK, Allore HG, Chen S, Malawista SE, et al. Increased TLR4 expression and downstream cytokine production in immunosuppressed adults compared to non-immunosuppressed adults. PLoS ONE 2010;5(6):e11343.
69. Foley P, Kazazi F, Biti R, Sorrell TC, Cunningham AL. HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology 1992;75:391-7.
70. Alpagot T, Remien J, Bhattacharyya M, Konopka K, Lundergan W, Duzguneş N. Longitudinal evaluation of prostaglandin E2 (PGE2) and periodontal status in HIV+ patients. Archives of Oral Biology 2007;52:1102-8.
71. Steidley KE, Thompson SH, McQuade MJ, Strong SL, Scheidt MJ, Van Dyke TE. A comparison of T4:T8 lymphocyte ratio in the periodontal lesion of healthy and HIV-positive patients. Journal of Periodontology 1992;63:753-6.
72. Odden K, Schenck K, Koppang H, Hurlen B. Candidal infection of the gingiva in HIV-infected persons. Journal of Oral Pathology and Medicine 1994;23:178-83.
73. Myint M, Yuan ZN, Schenck K. Reduced numbers of Langerhans cells and increased HLA-DR expression in Keratinocytes in the oral gingival epithelium of HIV-infected patients with periodontitis. Journal of Clinical Periodontology 2000;27:513-9.
74. Segundo TK, Souto GR, Mesquita RA, Costa FO. Langerhans cells in periodontal disease of HIV- and HIV+ patients undergoing highly active antiretroviral therapy. Brazilian Oral Research 2011;25:255-60.
75. Segundo TK, Souto GR, Costa FO, Mesquita RA. Mast cells in the periodontal disease of non-HIV-infected and HIV-infected individuals undergoing highly active antiretroviral therapy. Journal of Periodontology 2012. [Epub ahead of print].
76. Lamster IB, Grbic JT, Mitchell-Lewis DA, Begg MD, Mitchell A. New concepts regarding the pathogenesis of periodontal disease in HIV infection. Annals of Periodontology 1998;3:62-75.
77. Zambon JJ, Reynolds HS, Genco RJ. Studies of the subgingival microflora patients with acquired immunodeficiency syndrome. Journal of Periodontology 1990;61:699-704.
78. Murray PA, Winkler JR, Peros WJ, French CK, Lippke JA. DNA probe detection of periodontal pathogens in HIV-associated periodontal lesions. Oral Microbiology and Immunology 1991;6 :34-40.
79. Lucht E, Heimdahl A, Nord CE. Periodontal disease in HIV-infected patients in relation to lymphocyte subsets and specific micro-organisms. Journal of Clinical Periodontology 1991;18:252-6.
80. Rams TE, Andriolo Jr M, Feik D, Abel SN, McGivern TM, Slots J. Microbiological study of HIV-related periodontitis. Journal of Periodontology 1991; 62:74-81.
81. Moore LV, Moore WE, Riley C, Brooks CN, Burmeister JA, Smibert RM. Periodontal microflora of HIV positive subjects with gingivitis or adult periodontitis. Journal of Periodontology 1993;64:48-56.
82. Brady LJ, Walker C, Oxford GE, Stewart C, Magnusson I, McArthur W. Oral diseases, mycology and periodontal microbiology of HIV-1-infected women. Oral Microbiology and Immunology 1996;11:371-80.
83. Tenenbaum H, Elkaim R, Cuisinier F, Dahan M, Zamanian P, Lang JM. Prevalence of six periodontal pathogens detected by DNA probe method in HIV vs non-HIV periodontitis. Oral Diseases 1997;3(Suppl. I):S153-5.
84. Scully C, Porter SR, Mutlu S, Epstein JB, Glover S, Kumar N. Periodontopathic bacteria in English HIV seropositive persons. Aids Patient Care and STDS 1999;13:369-74.
85. Tsang CSP, Samaranayake LP. Predominant cultivable subgingival microbiota of health and HIV-infected ethnic Chinese. Journal of Oral Pathology & Medicine 2001;109:117-26.
86. Patel M, Coogan M, Galpin JS. Periodontal pathogens in subgingival plaque of HIV-positive subjects with chronic periodontitis. Oral Microbiology and Immunology 2003;18:199-201.
87. Gonçalves LS, Souto R, Colombo AP. Detection of Helicobacter pylori, Enterococcus faecalis, and Pseudomonas aeruginosa in the subgingival biofilm of HIV-infected subjects undergoing HAART with chronic periodontitis. European Journal of Clinical Microbiology & Infectious 2009;28:1335-42.
88. Giacaman RA, Nobbs AH, Ross KF, Herzberg MC. Porphyromonas gingivalis selectively up-regulates the HIV-coreceptor CCR5 in oral keratinocytes. Journal of Immunology 2007;179:2542-50.
89. Giacaman RA, Asrani AC, Gebhard KH, Dietrich EA, Vacharaksa A, Ross KF, et al. Porphyromonas gingivalis induces CCR5-dependent transfer of infectious HIV-1 from oral keratinocytes to permissive cells. Retrovirology 2008;5 :29.
90. Huang CB, Alimova YV, Strange S, Ebersole JL. Polybacterial challenge enhances HIV reactivation in latently infected macrophages and dendritic cells. Immunology 2011;132 :401-9.
91. Imai K, Ochiai K, Okamoto T. Reactivation of latent HIV-1 infection by the periodontopathic bacterium Porphyromonas gingivalis involves histone modification. Journal of Immunology 2009;182:3688-95.
92. Imai K, Ochiai K. Role of histone modification on transcriptional regulation and HIV-1 gene expression: possible mechanisms of periodontal diseases in AIDS progression. Journal of Oral Science 2011;53:1-13.
93. Chattin BR, Ishihara K, Okuda K, Hirai Y, Ishikawa T. Specific microbial colonizations in the periodontal sites of HIV-infected subjects. Microbiology and Immunology 1999;43:847-52.
94. Dongari-Bagtzoglou A, Fidel Jr PL. The host cytokine responses and protective immunity in oropharyngeal candidiasis. Journal of Dental Research 2005;84:966-77.
95. Back-Brito GN, Mota AJ, Vasconcellos TC, Querido SM, Jorge AO, Reis AS, et al. Frequency of Candida spp. in the oral cavity of Brazilian HIV-positive patients and correlation with CD4 cell counts and viral load. Mycopathologia 2009;167:81-7.
96. Junqueira JC, Vilela SF, Rossoni RD, Barbosa JO, Costa AC, Rasteiro VM, et al. Oral colonization by yeasts in HIV-positive patients in Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo 2012;54:17-24.
97. Teanpaisan R, Douglas CW, Nittayananta W. Isolations and genotyping of black-pigmented anaerobes from periodontal sites of HIV-positive and non-infected subjects in Thailand. Journal of Clinical Periodontology 2001;28:311-8.
98. Loesche WJ, Lopatin DE, Stoll J, van Poperin N, Hujoel PP. Comparison of various detection methods for periodontopathic bacteria: can culture be considered the primary reference standard? Journal of Clinical Microbiology 1992;30:418-26.
99. Loos BG, Van Winkelhoff AJ, Dunford RG, Genco RJ, De Graaff J, Dickinson DP, et al. A statistical approach to the ecology of Porphyromonas gingivalis. Journal of Dental Research 1992;71:353-8.
100. Haffajee AD, Socransky SS. Effect of sampling strategy on the false-negative rate for detection of selected subgingival species. Oral Microbiology and Immunology 1992;7:57-9.
101. Paster BJ, Russell MK, Alpagot T, Lee AM, Boches SK, Galvin JL, et al. Bacterial diversity in necrotizing ulcerative periodontitis in HIV-positive subjects. Annals of Periodontology 2002;7:8-16.
102. Cobb CM, Ferguson BL, Keselyak NT, Holt LA, MacNeill SR, Rapley JW. A TEM/SEM study of the microbial plaque overlying the necrotic gingival papillae of HIV-seropositive, necrotizing ulcerative periodontitis. Journal of Periodontal Research 2003;38:147-55.
103. Ramos MP, Ferreira SM, Silva-Boghossian CM, Souto R, Colombo AP, Noce CW, et al. Necrotizing periodontal diseases in HIV-infected Brazilian patients: a clinical and microbiological descriptive study. Quintessence International 2012;43:71-82.
104. Detels R, Tarwater P, Phair JP, Margolick J, Riddler SA, Muñoz A, Multicenter AIDS Cohort Study Multicenter AIDS Cohort Study. Effectiveness of potent antiretroviral therapy on the incidence opportunistic infection before and AIDS diagnosis. AIDS 2001;15:347-55.
105. Parra B, Slots J. Detection of human viruses in periodontal pockets using polymerase chain reaction. Oral Microbiology and Immunology 1996;5:289-93.
106. Contreras A, Umeda M, Chen C, Bakker I, Morrison JL, Slots J. Relationship between herpesviruses and adult periodontitis and periodontopathic bacteria. Journal of Periodontology 1999;70:478-84.
107. Ficarra G. Oral ulcerations in patients with HIV infection: etiology, diagnosis and management. In: Greenspan D, Greenspan JS, editors. Oral Manifestation of HIV Infection. Chicago: Quintessence Publishing Co Inc.; 1995. p. 205-17.
108. Dodd CL, Winkler JR, Heinic GS, Daniels TE, Yee K, Greenspan D. Cytomegalovirus infection presenting as acute periodontal infection in a patient infected with the human immunodeficiency virus. Journal of Clinical Periodontology 1993;20:282-5.
109. Contreras A, Slots J. Mammalian viruses in human periodontitis. Oral Microbiology and Immunology 1996;11:381-6.
110. Mardirossian A, Contreras A, Navazesh M, Nowzari H, Slots J. Herpesviruses 6, 7 and 8 in HIV and non HIV-associated periodontitis. Journal of Periodontal Research 2000;35:278-84.
111. Slots J, Contreras A. Herpersviruses: a unifying causative factor in periodontitis? Oral Microbiology and Immunology 2000;15:277-80.
112. Lin Y-L, Li M. Human cytomegalovirus and Epstein-Barr virus inhibit oral bacteria-induced macrophage activation and phagocytosis. Oral Microbiology and Immunology 2009;24:243-8.
113. Grande SR, Imbronito AV, Okuda OS, Pannuti CM, Nunes FD, Lima LA. Relationship between herpesviruses and periodontopathogens in patients with HIV and periodontitis. Journal of Periodontology 2011;82:1442-52.
114. Contreras A, Mardirossian A, Slots J. Herpesviruses in HIV-periodontitis. Journal of Clinical Periodontology 2001;28:96-102.
115. Michalowicz BS, Ronderos M, Camara-Silva R, Contreras A, Slots J. Human herpesviruses and Porphyromonas gingivalis are associated with juvenile periodontitis. Journal of Periodontology 2000;71:981-8.